NOBLE ROMANS INC

NROM
About the company

Noble Roman's, Inc., together with its subsidiaries, sells and services franchises in the United States. It also licenses and operates company-owned stand-alone restaurants and non-traditional foodservice operations under the Noble Roman's Craft Pizza & Pub, Noble Roman's Pizza, Noble Roman's Take-N-Bake, and Tuscano's Italian Style Subs brand names.

Country: United StatesPrice: $0.63Market Cap: $14.3M

Investment snapshot

12%positive consensus
Scored 1d ago

Positive

2

BUY / PASS

Neutral / negative

6 / 8

NEUTRAL / FAIL

Median fair value

$0.58

-7.1% vs price

Models with upside

4 / 17

Positive margin of safety

Strongest signal

5 of 8 pass — Graham, Dreman and Sleep object

Key risk

14 of 16 flag NROM's profitability — Graham, Buffett, Lynch +11 more

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILBUYNot rankedNEUTRALFAILNEUTRALFAILNEUTRALFAILNEUTRALFAILBUYNEUTRALFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/A
Margin of Safety-70.3%+7.4%+17.1%+27.6%N/A-14.5%-1.6%-57.5%-425.0%N/A+27.6%-530.0%N/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Annual history · FY 2025

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30 · TTM ended 2026-09-30 vs 2025-09-30 · TTM ended 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-06-08

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-06-08

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-06-08

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Qualitative assessment

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-06-08

Score computed: 2026-11-14

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

TTM ended 2026-09-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Where It Passes

  • Growth63% pass✓ 9✗ 4▾

    5 of 8 pass — Graham, Dreman and Sleep object

    EPS Growth (3-yr avg, 10-yr window)-33.3%
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)0.83
    ✓Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR18.9%
    ✓Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthInv: 1.4% vs Rev: 3.9%
    ✓LynchInventory growth < Revenue growth
    EPS Growth Direction$0.08 (2009) -> $0.04 (2025)
    ✗DremanPositive over recent years
    EPS CAGR-4.2% CAGR over 16 years
    ✗Dreman> 5% annualized
    Positive Net Income Frequency10/17 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth5.4%
    ✓Ackman>= 5%
    Positive EPS Growth Frequency3/5 years with positive EPS growth
    ✓AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR18.9% CAGR over 4 years
    ✓Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendrevenue up, operating margin 23.9% -> 14.6%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR7.4%
    ✓SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR18.9% over 4 years
    ✓Neff7%-20% annualized
  • Cash Flow60% pass✓ 8✗ 4▾

    6 of 10 pass — Buffett, Dreman, Pabrai +1 more object

    Free Cash Flow Proxy$1.4M
    ✗BuffettPositive and growing
    FCF Positive and Growing$1.1M
    ✓LynchPositive and growing
    Operating Cash Flow$1.2M
    ✓PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=7.83%, ROA=7.38%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)11.2x
    ✗Dreman< 8x
    P/E or FCF YieldP/E=15.7x, FCF Yield=7.7%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive13/17 years FCF positive
    ✓MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap10.5%
    ✓Ackman>= 4%
    Price / FCF per Share12.7x
    ✓Ackman<= 25
    Positive Operating Cash Flow frequency16/17 years positive
    ✓SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$1.5M
    ✓Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization+10.29%; #731/4519 (top 16.2%)
    ✗OshaughnessyTop 10% of eligible cross-section

Where It Falls Short

  • Profitability13% pass✓ 12✗ 23▾

    14 of 16 flag NROM's profitability — Graham, Buffett, Lynch +11 more

    Positive EPS (10 years)10/18 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)-33.3%
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)10/18 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)-13.3%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)14.6% (latest)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy$1.4M
    ✗BuffettPositive and growing
    Earnings Variance (10-yr CoV)N/A (negative mean EPS)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)0.83
    ✓Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR18.9%
    ✓Lynch15-30% (Fast Grower); > 0% to pass
    ROE13.8%
    ✗Lynch> 15%
    EBIT / Enterprise Value10.6%
    ✓Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=10.6%, ROC=N/A (invested capital <= 0)
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets7.38%
    ✓PiotroskiROA > 0
    ROA Change YoY-0.02% -> 7.38% (delta: +7.40%)
    ✓PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=7.83%, ROA=7.38%
    ✓PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY
    ✗PiotroskiImproved YoY
    Pre-Tax Income / Revenue6.5%
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity13.8%
    ✓Dreman> 12%
    Margin of SafetyP/E=15.7x, P/B=4.1x
    ✗PabraiP/B < 1.5 or P/E < 15
    Return on Equity33.6% (3-yr avg)
    ✓AkreROE > 20% (3-year avg)
    Discount to Intrinsic Value-26.0% (IV=$0.50 vs Price=$0.63)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency10/17 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue12.2%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity13.8%
    ✗Ackman>= 15%
    5-Year EPS CAGR18.9% CAGR over 4 years
    ✓Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend23.9% (2023) -> 14.6% (2025)
    ✗TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendrevenue up, operating margin 23.9% -> 14.6%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization+3.77%; #2104/6340 (top 33.2%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity+13.80%; #1297/5226 (top 24.8%)
    ✓AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.0552; #2695/5884 (top 45.8%)
    ✗AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR18.9% over 4 years
    ✓Neff7%-20% annualized
    Positive Diluted-EPS Years3/10 years positive
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Verdicts20% pass✓ 2✗ 8▾

    Split decision: 8 FAIL · 6 NEUTRAL · 2 BUY

    Overall verdict
    ✗GrahamFAIL (0/9)✗BuffettFAIL (2/9)✓LynchBUY (5/7)•GreenblattNot ranked•PiotroskiNEUTRAL (F-Score 7)✗DremanFAIL (2/11)•MungerNEUTRAL (3/4)✗PabraiFAIL (1/3)•AkreNEUTRAL (4/6)✗MarksFAIL (2/5)•AckmanNEUTRAL (6/9)✗TempletonFAIL (3/8)✓SleepBUY (5/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (3/6)✗SchlossFAIL (2/7)•OshaughnessyNEUTRAL (Not ranked)
  • Valuation23% pass✓ 6✗ 22▾

    10 of 13 flag NROM's valuation — Graham, Greenblatt, Dreman +7 more

    Price / 3-yr avg EPS18.9x
    ✗Graham<= 15x
    Price-to-Book Ratio4.1x
    ✗Graham<= 1.5x
    P/E x P/B77.10
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)0.83
    ✓Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value10.6%
    ✓Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=10.6%, ROC=N/A (invested capital <= 0)
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS15.7x
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)11.2x
    ✗Dreman< 8x
    Price / Book Value per Share4.1x
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessP/E=15.7x, OE Yield=10.2%
    ✓MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldP/E=15.7x, FCF Yield=7.7%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/E=15.7x, P/B=4.1x
    ✗MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic Value-26.0% (IV=$0.50 vs Price=$0.63)
    ✗Marks>= 20% below intrinsic value
    Price / FCF per Share12.7x
    ✓Ackman<= 25
    Price vs. Trailing Low371% of trailing low ($0.17)
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization+3.77%; #2104/6340 (top 33.2%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+0.2734; #3819/6449 (top 59.2%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS15.7x
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per Share4.44x
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change+45.6%
    ✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+1.1394; #1634/5247 (top 31.1%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization+10.29%; #731/4519 (top 16.2%)
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date+85.29%; #400/6202 (top 6.4%)
    ✓OshaughnessyTop 10% of eligible cross-section
  • Debt & Leverage33% pass✓ 7✗ 8▾

    8 of 12 flag NROM's debt & leverage — Graham, Buffett, Lynch +5 more

    Debt Levels0.31
    ✓MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
    LT Debt vs Net Current Assets
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 0.31, IC: 1.8x
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity0.31
    ✓Lynch< 0.33
    Cash - Long-term Debt
    ✗LynchPositive preferred
    LT Debt / Total Assets Change0.00% -> 0.00%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities1.40
    ✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity0.31
    ✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
    Interest Coverage & Debt/EBITDAIC=1.8x, D/EBITDA=0.5x
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity0.31
    ✓Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-0.3055; #2009/4210 (top 47.7%)
    ✗AsnessTop 30% of eligible cross-section
  • Valuation models40% pass✓ 4✗ 6▾

    Models split on NROM at $0.63 — fair values range $0.10–$0.87

    Graham fair value$0.37
    ✗Graham-70.3% margin vs $0.63
    Buffett fair value$0.68
    ✓Buffett+7.4% margin vs $0.63
    Lynch fair value$0.76
    ✓Lynch+17.1% margin vs $0.63
    Greenblatt fair value$0.87
    ✓Greenblatt+27.6% margin vs $0.63
    Dreman fair value$0.55
    ✗Dreman-14.5% margin vs $0.63
    Munger fair value$0.62
    ✗Munger-1.6% margin vs $0.63
    Pabrai fair value$0.40
    ✗Pabrai-57.5% margin vs $0.63
    Akre fair value$0.12
    ✗Akre-425.0% margin vs $0.63
    Ackman fair value$0.87
    ✓Ackman+27.6% margin vs $0.63
    Templeton fair value$0.10
    ✗Templeton-530.0% margin vs $0.63
  • Efficiency50% pass✓ 7✗ 4▾

    4 of 8 pass — Graham, Greenblatt, Piotroski +1 more object

    Current Ratio1.40
    ✗Graham>= 2.0
    ROIC (3-5 yr avg)38.5%
    ✓Buffett> 10%
    ROIC - WACC+28.5%
    ✓BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)N/A (invested capital <= 0)
    ✗Greenblatt> 25%
    Current Ratio Change YoY0.90 -> 0.40
    ✗PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY0.90x -> 1.04x
    ✓PiotroskiImproved YoY
    Current Assets / Current Liabilities1.40
    ✗Dreman> 1.5
    Return on Invested Capital30.8%
    ✓Munger> 15%
    ROIC (high and growing)FY2023: ROIC=32.5%; FY2024: ROIC=15.2%; FY2025: ROIC=15.3%
    ✓AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROIC15.3% (RR=100% x ROIC=15.3%)
    ✓AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)5/5 years above 12% (latest 15.3%)
    ✓SleepROIC > 12% in a majority of years

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Restaurants, Hotels, Motels
SIC Sector: Eating & Drinking Places
Size: Micro Cap($14.3M)
Revenue: $16.5M+8.7% YoY
Net Income: $1.2M+37063.6% YoY

Financial Snapshot

Operating Margin14.6%
Return on Equity34.2%
Debt / Equity2.62
Current Ratio0.40
EPS (Diluted)$0.04
Shares Retired0.0% / 0.0% 2y

Similar Companies

MCDMCDONALDS CORP
$192.0B
SBUXSTARBUCKS CORP
$121.4B
MARMARRIOTT INTERNATIONAL INC /MD/
$109.0B
YUMYUM BRANDS INC
$43.3B

Shareholder Return

Fiscal 2025

Retired 0.0% of shares last year, 0.0% over two.

Buybacks
—
Dividends
—

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-09-30

2025-10-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: revenue, net income, operating income, ebit, pre tax income, interest expense, operating cash flow, depreciation amortization, capex.

Q3 FY 2026

2026-07-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex.

Q2 FY 2026

2026-04-01 – 2026-06-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex.

Q1 FY 2026

2026-01-01 – 2026-03-31

Sources
FY 2025
Sources
  • 10-K · 2026-06-08
FY 2024
Sources
  • 10-K · 2025-06-09
FY 2023
Sources
  • 10-K · 2025-06-09
FY 2022
Sources
  • 10-K · 2023-04-13
FY 2021
Sources
  • 10-K · 2023-04-13
Market Cap$14.3Mcurrent------$8.0Mest.$9.1Mest.$6.7Mest.$8.4Mest.$7.6Mest.
Revenue$16.3M↑4%$3.8M↓8%$4.1M↑1%$3.9M↑4%$16.5M↑9%$15.1M↑5%$14.4M↓1%$14.5M↑4%$13.9M
Operating Income$2.0M↓14%$556.0K↓32%$712.7K↓22%$550.5K↑10%$2.4M↑63%$1.5M↓57%$3.4M↑704%$427.7K↓75%$1.7M
Net Income$539.8K↓45%$84.7K↓87%$190.6K↓49%$232.5K↑78%$1.2M↑37064%-$3.2K↓100%$1.5M↑211%-$1.3M↓358%$509.5K
EPS (Diluted)--$0.00↓100%$0.01↓50%$0.01$0.04$0.00↓100%$0.06↑220%$-0.05↓350%$0.02
Gross Margin—————————
Operating Margin12.2%↓17%14.7%↓26%17.3%↓23%14.1%↑6%14.6%↑50%9.7%↓59%23.9%↑709%3.0%↓76%12.6%
ROE13.8%↓52%———34.2%↑23960%-0.1%↓100%66.7%↑136%-185.0%↓1151%17.6%
Total Debt$1.2M↑108%$1.2M↑108%$6.4M↑1012%$5.2M↑806%$9.0M↑65%$5.4M↓12%$6.2M↑892%$622.9K↑4%$597.2K
Shareholders' Equity$3.9M↑16%$3.9M↑16%$3.8M↑39%$3.7M↑56%$3.4M↑55%$2.2M↑1%$2.2M↑208%$710.2K↓75%$2.9M
Current Ratio1.40↑253%1.40↑253%1.33↑39%0.42↓52%0.40↓56%0.90↓15%1.06↑22%0.87↓62%2.27
Debt / Equity0.31↑80%0.31↑80%1.68↑698%1.42↑480%2.62↑7%2.46↓13%2.82↑222%0.88↑325%0.21
Operating Cash Flow$1.6M↑22%$152.1K↓58%$804.4K↑102%$322.5K↑104%$1.2M↑53%$813.6K↓48%$1.6M↑5202%$29.6K↓98%$1.5M
Free Cash Flow$1.5M$119.8K↓61%$771.4K↑118%$280.7K↑102%$1.1M↑52%$725.3K↓53%$1.6M↑425%-$478.0K↓791%$69.2K

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Restaurants, Hotels, Motels

NROM vs Peers — Financial Grading

Revenue$16.5MBottom 25%
Net Income$1.2MBottom 25%
ROE34.2%Top 25%
D/E2.62Bottom 25%
Op. Margin14.6%Median
Curr. Ratio0.40Bottom 25%
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
MCDONALDS CORPMCD$192.0B$271.97$26.9B$8.6B-478.1%-22.7246.1%0.952/96/92/71/3F-Score 54/11
STARBUCKS CORPSBUX$121.4B$106.44$37.2B$1.9B-22.9%-1.997.9%0.722/96/92/71/3F-Score 52/11
MARRIOTT INTERNATIONAL INC /MD/MAR$109.0B$423.16$26.2B$2.6B-69.0%-4.3015.8%0.432/94/94/71/3F-Score 72/11
YUM BRANDS INCYUM$43.3B$161.33$8.2B$1.6B-21.3%-1.6331.3%1.352/95/93/71/3F-Score 52/11
INTERCONTINENTAL HOTELS GROUP PLC /NEW/IHG$26.2B$179.93$5.2B$758.0M-27.7%-1.5323.1%0.981/92/92/71/3F-Score 72/11
DARDEN RESTAURANTS INCDRI$25.9B$228.74$13.2B$1.2B54.7%1.0912.0%0.313/95/93/71/3F-Score 75/11
Hyatt Hotels CorpH$17.5B$187.70$7.1B$52.0M-1.6%1.28—0.752/91/92/71/3F-Score 42/11
Yum China Holdings, Inc.YUMC$17.1B$50.86$11.8B$929.0M17.3%0.0210.9%1.052/94/94/71/3F-Score 76/11